Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)
Clinical trial NCT06424717 · WITHDRAWN
Trial details
- NCT number
- NCT06424717
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-16
- Primary completion
- 2026-01-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.